tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Revenue

Compare
322 Followers

Immunome Revenue

Immunome had a revenue of 4.01M in the quarter ending Jun 30, 2025, with 37.22%. This bring the company's revenue in the last twelve months to 12.59M, Decreased 15.09%. In the fiscal year ending Dec 31, 2024, Immunome had annual revenue of 9.04M with -35.50% growth.
Revenue (ttm)
12.59M
Revenue Growth
16.74%
P/S Ratio
98.97
Revenue/Employee
$69,015
Employees
131
Market Cap
$894.82M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
9.04M-4.98M-35.50%
Dec 31, 2023
14.02M+∞%
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis